Bostik v Henkel France (CFI, 31 July 2026)
| Date | 31 July 2026 |
|---|---|
| Court | CFI |
| Division | Paris (FR) Local Division |
| Type of action | Infringement Action |
| Case number(s) | UPC_CFI_583/2025 |
| Registry reference | UPC_CFI_583/2025 |
| Parties | Bostik, Inc. v. Henkel France, Henkel France Operations, Henkel Technologies France, Henkel AG & Co. KGaA, Henkel Nederland B.V., Henkel Italia |
Official decision (PDF) · UPC registry entry
Case timeline
- 4 February 2026 : Bostic v Henkel France (CFI, 4 February 2026) UPC_CFI_583/2025
- 16 June 2026 : Bostik v Henkel France (CFI, 16 June 2026) UPC_CFI_583/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
In a decision of 31 July 2026, the Paris Local Division revokes in its entirety Bostik’s European patent EP 1 725 627 (cohesive coating for snack food packaging), which had already expired, for added matter, and consequently dismisses the infringement action brought against six Henkel group companies. The decision is given in the infringement action UPC_CFI_583/2025 and the counterclaim for revocation UPC_CFI_1435/2025.
The decision is of interest for its application of the intermediate generalisation concept to a numerical threshold: the application disclosed a minimum bond strength applying to both cohesion and adhesion, and a claim limited to cohesive strength covers embodiments the application did not disclose. It also confirms that maintenance of the patent by the EPO is no answer to an added matter attack the EPO never examined.
Facts and procedure
On 4 July 2025 Bostik sued Henkel France, Henkel France Operations, Henkel Technologies France, Henkel AG & Co. KGaA, Henkel Nederland B.V. and Henkel Italia over Loctite Liofol cold-seal products, for France, Germany, Italy, the Netherlands, Spain and the United Kingdom (paragraph 4). Henkel counterclaimed for revocation. Bostik filed three conditional auxiliary requests to amend (paragraphs 5 and 6). The language of the proceedings was changed from French to English on 8 September 2025 (paragraph 9). On 29 May 2026 Bostik withdrew its claims for two of the four products (paragraphs 14 and 17).
The patent, granted on 1 October 2018, expired on 11 February 2025 (paragraph 18). An opposition filed by Henkel in 2009 ended, after two rounds before the Board of Appeal, with the patent maintained as granted in 2022, the late-filed added matter ground had been held not prima facie relevant by the Opposition Division (paragraph 19). Jurisdiction of the Paris Local Division was undisputed (paragraph 16).
The applicable law
Art. 138(1)(c) EPC allows revocation where the subject-matter of the patent extends beyond the content of the application as filed (paragraph 66). The court applies the Court of Appeal test: there is added matter where the granted claim goes beyond what the skilled person would derive directly and unambiguously from the application as filed, implicit disclosure included (paragraph 67). The claim is construed under Art. 69 EPC and its Protocol.
Question
Is claim 1, which requires a cohesive strength of the closure of at least 118.11 g/cm (feature 1.2.2) without any minimum adhesive strength, an unallowable intermediate generalisation?
Decision
Yes. The only reference to 118.11 g/cm in the application as filed is in paragraph [0005] and concerns the bond strength of the closure (paragraph 72). The application does not use the terms adhesive or cohesive strength: the measured strength is that of whichever bond fails first, so a minimum bond strength implies that both adhesion and cohesion exceed the threshold (paragraphs 73 to 75). The cohesive minimum is therefore implicitly disclosed, but leaving the adhesive minimum out of the claim is an intermediate generalisation (paragraph 76). Claim 1 covers closures with an adhesive strength below 118.11 g/cm, for which the application provides no support (paragraphs 77 and 78).
The court does not rule on insufficiency, novelty or inventive step (paragraph 79). The auxiliary requests, which concern the composition, do not address added matter and are not examined (paragraph 80). The operative part records the partial withdrawal, declares the patent invalid in its entirety and in its amended form based on auxiliary request AR1, dismisses the infringement action and orders Bostik to bear all the costs (Rule 118.5 RoP and Art. 69 UPCA, paragraph 82).
Key points for practice
- A numerical value linked in the application to an overall concept (bond strength) cannot be claimed for only one of its components without an intermediate generalisation.
- Maintenance of the patent after opposition does not prevent revocation for added matter where the EPO did not examine that ground on the merits (paragraphs 19 and 68).
- Auxiliary requests confined to the composition are set aside unexamined if they do not cure the ground of invalidity upheld (paragraph 80).
- Practical point: where the application defines a threshold only for the bond as a whole, check that the claim and the auxiliary requests carry that threshold over to every failure mode.
Provisions applied
- Agreement on a Unified Patent Court
- Arts. 32, 33, 69 and 73
- Rules of Procedure
- Rules 36, 118.5, 190 and 220.1
- European Patent Convention
- Art. 69, Art. 138(1)(c)
- Regulation (EU) No 1215/2012
- Arts. 4(1) and 8(1)
- Case law cited
- NanoString v 10x Genomics, Court of Appeal, 26 February 2024, VusionGroup v Hanshow, Court of Appeal, 13 May 2024, Abbott v Sibio, Court of Appeal, 14 February 2025, Insulet v EOFlow, Court of Appeal, 30 April 2025, Meril v Edwards, Court of Appeal, 25 November 2025 (UPC_CoA_646/2024), Sinocare v Menarini Diagnostics, Court of Appeal, 30 March 2026, Abbott v Sinocare, Court of Appeal, 17 April 2026
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Patent infringement action.
Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantBostik, Inc.Follow this party
- defendantHenkel France3 decisions in the corpusFollow this party
- defendantHenkel France Operations3 decisions in the corpusFollow this party
- defendantHenkel Technologies France3 decisions in the corpusFollow this party
- defendantHenkel AG & Co. KGaA3 decisions in the corpusFollow this party
- defendantHenkel Nederland B.V.3 decisions in the corpusFollow this party
- defendantHenkel Italia3 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 4 February 2026 Bostic v Henkel France (CFI, 4 February 2026) Infringement Action · UPC_CFI_583/2025
- 16 June 2026 Bostik v Henkel France (CFI, 16 June 2026) Infringement Action · UPC_CFI_583/2025
Les demandes d’exclusion d’arguments et de pièces sont rejetées, la valeur du litige est fixée à 6 millions d’euros et l’homme du métier est défini.
- 31 July 2026 Bostik v Henkel France (CFI, 31 July 2026) Infringement Action · UPC_CFI_583/2025
What the record states
- Nature of the act
- Infringement Action
- Outcome (Dhenne Avocats summary)
- Le brevet EP 1 725 627 est annulé en totalité pour extension au-delà de la demande, la revendication ne retenant le seuil de 118,11 g/cm que pour la résistance cohésive. L'action en contrefaçon est rejetée.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 1 725 627mentioned in: summary of the decision, Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Bostik v Henkel France (CFI, 16 June 2026) cited in this record
- Abbott Diabetes Care v Sinocare (CoA, 17 April 2026) cited in this record
- Sinocare v Abbott Diabetes Care (CoA, 30 March 2026) cited in this record
- Bostic v Henkel France (CFI, 4 February 2026) cited in this record
- Insulet v EOFLOW (CoA, UPC_CoA_768/2024, 1 May 2025) cited in this record
- Abbott Diabetes Care v Sibio (CoA, 14 February 2025) cited in this record
- SES-imagotag v Hanshow (CoA, 13 May 2024) cited in this record
- NanoString Technologies v 10x Genomics (CoA, 26 February 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 1 725 627 | Patent at issue according to the summary or official headnote Also mentioned in 1 other decision(s): Bostik v Henkel France (CFI, 16 June 2026) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: summary of the decision, Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.